Fully covered self-expandable metal stent for intraprocedural or late-diagnosed Type-II endoscopic retrograde cholangiopancreatography-related perforations

Table 2 Comparison of the conventional therapy and the FCSEMS Groups

	Conventional therapy (n = 9)	FCSEMS (n = 19)	P
Leukocyte-/μL (median)*	14.250 (5.280–23.970)	12.700 (6.370–26.890)	0.507
CRP-mg/L (median)*	198.00 (2.00–306.00)	116.00 (1.90–341.00)	0.121
Length of stay- day (median, min–max)	10 (7–34)	7 (2–14)	0.012
Need of percutaneous drainage or surgery (n)	2	0
Mortality (n)	0	0

The statistically significant values are written in bold
^*The highest values in the first 7 days, FCSEMS, Fully covered self-expandable metal stent

ISSN: 1471-230X